2025 Point-of-Care Testing Conference

This event is made possible by the generosity of the following sponsors.

Ruby sponsors

Siemens Healthineers

Siemens Healthineers’ Point of Care testing solutions are designed to provide rapid, convenient, and easy-to-use diagnostic testing across primary care and critical care settings. From the ED to the physician’s office, clinical management decisions can be made rapidly and result in improved patient safety, clinical outcomes, and overall patient satisfaction. Their POCT portfolio includes solutions for blood gas, diabetes, and urinalysis testing—delivering lab-quality results at the patient’s side in minutes. Integrated POCT Informatics solutions ensure seamless connectivity, compliance, and workflow efficiency. Siemens Healthineers empowers healthcare providers to make confident, timely decisions wherever patient care is delivered.

BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

BioMérieux

Pioneering Diagnostics. A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached €4 billion, with over 93% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, and services), which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. 

HemoSonics

HemoSonics' Quantra® Hemostasis System is revolutionizing bleeding management with its next-generation whole-blood viscoelastic analyzer. It boasts the widest range of indications among cartridge-based analyzers, spanning cardiovascular, orthopedic, trauma, and liver transplant surgeries. The Quantra System provides rapid, precise, and easy-to-interpret coagulation results, cutting unnecessary blood expenditure and waste while reducing transfusion-related complications and improving patient outcomes. HemoSonics is a Stago Group company. Stago is a global leader in hemostasis and thrombosis. For more information, visit: www.hemosonics.com and www.stago.com.

Roche

Roche provides innovative diagnostic solutions to increase productivity in pathology labs and to help healthcare providers make faster, more confident decisions. Our Near Patient Care portfolio includes a broad menu of CLIA-waived diagnostic assays, including rapid molecular and hospital glucose monitoring solutions. We partner with our customers to improve workflow efficiency, deliver enhanced medical value, and ensure safety for both the user and the patient.

TELCOR

TELCOR QML® is the leading point of care middleware solution providing connectivity and data management to more POC device types and LIS/EMR systems than any other provider in the industry. We are the only middleware vendor with no diagnostic or LIS company ownership allowing the complete freedom of device type choice to the customer. With more than 2,600 hospitals and thousands of ambulatory locations all connecting results through QML, we excel at helping point of care teams see it all, speed it up, and solve anything together. Our 97% customer retention rate confirms how TELCOR helps customers reach for more.

Werfen

Werfen is a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics and Autoimmunity. Our comprehensive and integrated Acute Care Diagnostics line is comprised of whole-blood testing systems to help achieve better patient outcomes, lower total cost of care, assure regulatory compliance and enhance operational efficiency in hospital settings. Key products include our GEM® Premier™ blood gas systems, as well as the whole-blood hemostasis family, featuring ROTEM®, Hemochron® and VerifyNow™ systems.